Skip to content

Bayer introduces medication for chronic kidney disease

The drug is a non-steroidal, selective mineralocorticoid receptor antagonist indicated for patients with chronic kidney disease associated with type 2 diabetes.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish